Antibiotic News and Research

RSS
Mandell, Douglas, and Bennett's publication on infectious diseases released

Mandell, Douglas, and Bennett's publication on infectious diseases released

Biochemists are developing a new system to better understand antibiotic resistance

Biochemists are developing a new system to better understand antibiotic resistance

New vaccine may prove effective against urinary tract infections

New vaccine may prove effective against urinary tract infections

Book on the effects of antibiotic-resistant microbes

Book on the effects of antibiotic-resistant microbes

OCLS' partnership with V&M Industries to market Microcyn-based skin and wound care products

OCLS' partnership with V&M Industries to market Microcyn-based skin and wound care products

Nomir publishes efficacy of the Noveondual-wavelength device against infectious disease pathogens

Nomir publishes efficacy of the Noveondual-wavelength device against infectious disease pathogens

LEAD Therapeutics' LT-29 antibiotic effective against most common antibiotic resistant bacteria

LEAD Therapeutics' LT-29 antibiotic effective against most common antibiotic resistant bacteria

Optimer's North American phase 3 Fidaxomicin study results presented at the 49th ICAAC

Optimer's North American phase 3 Fidaxomicin study results presented at the 49th ICAAC

FDA grants orphan drug status to Advanced Life Sciences' Restanza

FDA grants orphan drug status to Advanced Life Sciences' Restanza

Antibiotics sold online without prescriptions, according to MUSC researchers

Antibiotics sold online without prescriptions, according to MUSC researchers

NovaBay's Aganocide compounds effective against multidrug-resistant bacteria

NovaBay's Aganocide compounds effective against multidrug-resistant bacteria

Rib-X and NIAID collaborate to develop an antibiotic treatment for N. gonorrhoeae

Rib-X and NIAID collaborate to develop an antibiotic treatment for N. gonorrhoeae

Positive results from Merck's Phase IIB clinical study of odanacatib for treating osteoporosis

Positive results from Merck's Phase IIB clinical study of odanacatib for treating osteoporosis

Phase 2b trial of Mpex's Aeroquin with PARI Pharma's eFlow Nebulizer System successful

Phase 2b trial of Mpex's Aeroquin with PARI Pharma's eFlow Nebulizer System successful

Environmental Solutions International introduces unique, alcohol-free, moisturizing hand sanitizers

Environmental Solutions International introduces unique, alcohol-free, moisturizing hand sanitizers

AzaSite production increased to combat erythromycin ophthalmic ointment shortage

AzaSite production increased to combat erythromycin ophthalmic ointment shortage

Phase 1 trial results of Achaogen's ACHN-490 announced at ICAAC meeting

Phase 1 trial results of Achaogen's ACHN-490 announced at ICAAC meeting

Positive results from Transave's Phase II clinical trial of ARIKACE in non-CF bronchiectasis patients

Positive results from Transave's Phase II clinical trial of ARIKACE in non-CF bronchiectasis patients

Data from Phase 1 and Phase 2a studies of inhaled liposomal ciprofloxacin to be presented at ERS Congress

Data from Phase 1 and Phase 2a studies of inhaled liposomal ciprofloxacin to be presented at ERS Congress

Phase 3 results of TARGET 1 and TARGET 2 clinical trials released

Phase 3 results of TARGET 1 and TARGET 2 clinical trials released

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.